Stephen Willard - 12 Jul 2022 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Executive Officer, Director
Signature
/s/ Stephen Willard
Issuer symbol
NRXP
Transactions as of
12 Jul 2022
Net transactions value
$0
Form type
3
Filing time
22 Jul 2022, 16:27:29 UTC
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NRXP Restricted Common Stock, par value $0.001 per share 1,000,000 12 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of an inducement award of 1,000,000 restricted shares of the Company's common stock. The restricted shares will vest in approximately equal installments over three (3) years from July 12, 2022, subject generally to the reporting person's continued service to the Company through the applicable vesting date.